via Imperial College London
By attaching specialised molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
The presence of, or changes in the concentration of, certain proteins in biological fluids can be indicators of disease. However, in the early stages of disease these ‘biomarkers’ can be difficult to detect, as they are relatively rare.
We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.– Dr Alex Ivanov
Detecting important biomarkers in lower concentrations will allow patients to be treated earlier for diseases such as some cancers and neurological disorders, which could increase the chance of survival rate.
However, current methods of detection are often not sufficiently sensitive and require costly and time-consuming sample pre-treatment.
Now, researchers from the Department of Chemistry at Imperial College London have come up with a system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood).
The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation. The method is published in Nature Communications.
Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: “The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.”
Binding to biomarkers
The method the team developed uses the ‘backbone’ of DNA, the structure it is built around. They grafted ‘aptamers’ – synthetic DNA molecules that bind to specific target biomarkers – to DNA backbones.
When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them.
Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.
With the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.– Dr Jasmine Sze
The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.
They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.
Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.
The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.
Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said “Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
“It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity.”
Learn more: Early disease diagnosis could be dramatically improved with new detection system
The Latest on: Disease diagnosis
- King’s College London: Three types of long-COVID for people experiencing symptoms for 12 weeks or moreon August 1, 2022 at 10:38 pm
The pre-print, published today on MedrXiv, also identifies patterns among people infected with the wild-type, the first strain of SARS-CoV-2, and Delta and Alpha variants, among vaccinated and ...
- Commentary: Cardiomyopathy is scary, but the heart disease is less deadly todayon August 1, 2022 at 9:15 pm
Heart disease remains America’s leading killer. But medical innovations have made cardiomyopathy, a.k.a. the scary-sounding condition “heart failure,” less of a threat.
- Microscopic blood vessel disease in the brain’s white matter associated with worse cognition in Alzheimer’son August 1, 2022 at 9:02 pm
Disease of the microscopic blood vessels that feed the white matter of our brain is associated with worse cognitive function and memory deficits in individuals with Alzheimer’s, scientists report.
- Heartbreak as man dies months after being diagnosed with rare brain diseaseon August 1, 2022 at 9:00 pm
His friend has now cycled all the way from the Netherlands to Knaresborough to raise money for the hospice which looked after him and the campaign to cure the rare disease ...
- Inside Colorado’s Battle Against Rare Diseaseson August 1, 2022 at 4:51 pm
One in 10 Centennial Staters has a so-called orphan disease—the local medical community is trying to help them.
- Doctors Explain These Are the First Symptoms of Monkeypox to Look Out Foron August 1, 2022 at 12:00 pm
With thousands of cases reported in countries all around the world, chances are you’ve been seeing a lot of news surrounding Monkeypox 2022 lately. With COVID still affecting all of our lives, adding ...
- Bacteria that causes rare tropical disease found on Gulf Coaston August 1, 2022 at 8:52 am
A germ that causes a rare and possible fatal disease has been found in soil and water along the Gulf Coast, health officials said.
- 'I was diagnosed with a bowel disease 15 years ago and had life-saving surgery'on August 1, 2022 at 4:18 am
The long-term bowel condition causes the colon and rectum to become inflamed, with recurring diarrhoea, stomach pains and needing to go to the toilet often. At the time of her diagnosis, Natalie had ...
- Cardiomyopathy is scary. But today, the heart disease is less deadly.on August 1, 2022 at 4:17 am
Heart disease remains America’s leading killer. But medical innovations have made cardiomyopathy, a.k.a. the scary-sounding condition “heart failure,” less of a threat. Cardiomyopathy affects ...
- Bacteria behind melioidosis, a deadly tropical disease, found in US for 1st timeon July 30, 2022 at 4:00 am
The bacteria behind the potentially fatal disease melioidosis has been found in U.S. soil for the first time, the Centers for Disease Control and Prevention (CDC) announced Wednesday (July 27).
via Google News and Bing News
